SCHEMBL24850282

SCHEMBL24850282

O=c1c2ccccc2[nH]c2ccc(NS)cc12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 2/20 0.67
GAA P10253 3/20 0.60
KDM4E B2RXH2 3/20 0.60
ALDH1A1 P00352 3/20 0.60
GLA P06280 2/20 0.60
HTT P42858 2/20 0.60
LMNA P02545 1/20 0.60
HPGD P15428 1/20 0.60
ATM Q13315 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
KMT2A Q03164 3/20 0.58
MEN1 O00255 2/20 0.58
POLB P06746 2/20 0.58
NPC1 O15118 1/20 0.58
CASP6 P55212 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
ABCG2 Q9UNQ0 1/20 0.54
CTSV O60911 1/20 0.53
CTSL P07711 1/20 0.53
MTNR1A P48039 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24833958 0.83 KMT2A (0.63) P2RY12GAAKDM4EALDH1A1GLA
SCHEMBL7931748 0.82 P2RY12 (0.82) P2RY12GAAKDM4EALDH1A1GLA
SCHEMBL7840881 0.82 P2RY12 (0.61) P2RY12GAAKDM4EALDH1A1GLA
SCHEMBL24851241 0.80 P2RY12 (0.62) P2RY12GAAKDM4EALDH1A1GLA
SCHEMBL92077 0.78 GAA (0.82) P2RY12GAAKDM4EALDH1A1GLA
SCHEMBL22367061 0.78 GAA (0.82) P2RY12GAAKDM4EALDH1A1GLA
SCHEMBL13412901 0.78 GAA (0.82) P2RY12GAAKDM4EALDH1A1GLA
SCHEMBL29349876 0.78 GAA (0.82) P2RY12GAAKDM4EALDH1A1GLA
Acridone SCHEMBL29641306 0.78 ALDH1A1 (1.00) GAAKDM4EALDH1A1GLAHTT
Acridone SCHEMBL29360611 0.78 ALDH1A1 (1.00) GAAKDM4EALDH1A1GLAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024146906-A1 CASPASE-2 INHIBITOR COMPOUNDS Kintsugi Therapeutics S.L. (ES) 2024-07-11 WO disclosed
WO-2023275357-A1 CASPASE-2 INHIBITOR COMPOUNDS Kintsugi Therapeutics S.L. (ES) 2023-01-05 WO disclosed